Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Star Bulk Carriers Corp — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B), while Star Bulk Carriers Corp trades at $28.35 (market cap $3.34B). The key difference: Oruka Therapeutics Inc. Common Stock is the larger of the two by market cap, and Star Bulk Carriers Corp pays a 6.53% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Star Bulk Carriers Corp for 23 Days on average.
| ORKA | SBLK | |
|---|---|---|
Market Cap | $5.08B | $3.34B |
Volume | 685,276 | 1,935,552 |
Sector | Health | Industrials |
52-Week High | $113.08 | $32.49 |
52-Week Low | $26.19 | $17.42 |
Typical Hold Time | 0 Days | 23 Days |
Enterprise Value | $4.21B | $4.02B |
Dividend Yield | — | 6.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Star Bulk Carriers (SBLK) trades at $29.79, down 0.17% on the day, with a bearish technical signal from moving averages despite neutral oscillators. The company demonstrates strong fundamental performance, with Q2 2026 EPS of $1.21 beating expectations and a 23.87% net income margin. Recent news highlights insider buying and a declared $0.90 dividend, reflecting management confidence and shareholder returns.
SBLK presents a compelling value case with a P/E of 11.28 and robust profitability, though near-term technical weakness and shipping market volatility pose risks. Analyst consensus is bullish with 14 buy ratings, supporting upside potential if earnings momentum continues into Q3.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
